{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:17:53Z","timestamp":1754151473564,"version":"3.41.2"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2025,7,15]]},"DOI":"10.2169\/internalmedicine.4648-24","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T17:14:01Z","timestamp":1735146841000},"page":"2192-2196","source":"Crossref","is-referenced-by-count":0,"title":["Improvement and Retention of Insulin Secretion in Slowly Progressive Type 1 Diabetes Mellitus by Diet Therapy and Exercise for Five Years"],"prefix":"10.2169","volume":"64","author":[{"given":"Toshihiro","family":"Sato","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan"},{"name":"Department Diabetes, Metabolism and Endocrinology, Tohoku University graduate school of medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Tsujimoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan"},{"name":"Department of Diabetes and Endocrinology, Toranomon Hospital Kajigaya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michi","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nishimura A, Matsumura K, Kikuno S, et al. Slowly progressive type 1 diabetes mellitus: current knowledge and future perspectives. Diabetes Metab Syndr Obes 12: 2461-2477, 2019.","DOI":"10.2147\/DMSO.S191007"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Araki E, Goto A, Kondo T, et al. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int 11: 165-223, 2020.","DOI":"10.1007\/s13340-020-00439-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shimada A, Kawasaki E, Abiru N, et al. New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version). J Diabetes Investig 15: 254-257, 2024.","DOI":"10.1111\/jdi.14121"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Maruyama T, Tanaka S, Shimada S, et al. Insulin intervention in slowly progressive insulin dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab 93: 2115-2121, 2008.","DOI":"10.1210\/jc.2007-2267"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Awata T, Shimada A, Maruyama T, et al. Possible long-term ef\ufb01cacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, for slowly progressive type 1 diabetes (SPIDDM) in the stage of non-insulin-dependency: an open-label randomized controlled pilot trial (SPAN-S). Diabetes Ther 8: 1123-1134, 2017.","DOI":"10.1007\/s13300-017-0299-7"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Buzzetti R, Tuomi T, Mauricio D, et al. Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel. Diabetes 69: 2037-2047, 2020.","DOI":"10.2337\/dbi20-0017"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Waibel M, Wentworth JM, So M, et al. Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes. N Engl J Med 7; 389: 2140-2150, 2023.","DOI":"10.1056\/NEJMoa2306691"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Herold KC, Bundy BN, Long A, et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N Engl J Med 381: 603-613, 2019.","DOI":"10.1056\/NEJMoa1902226"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Herzog K, Ahlqvist E, Alfredsson L, et al. Combined lifestyle factors and the risk of LADA and type 2 diabetes - results from a Swedish population-based case-control study. Diabetes Res Clin Pract 174: 108760, 2021.","DOI":"10.1016\/j.diabres.2021.108760"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kawasaki E, Awata T, Ikegami H, et al. Prediction of future insulin-deficiency in glutamic acid decarboxylase autoantibody enzyme-linked immunosorbent assay-positive patients with slowly-progressive type 1 diabetes. J Diabetes Investig 15: 835-842, 2024.","DOI":"10.1111\/jdi.14178"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Kawabata Y, Ikegami H, Awata T, et al. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia 52: 2513-2521, 2009.","DOI":"10.1007\/s00125-009-1539-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Huang H, Farmer K, Windscheffel J, et al. Exercise increases insulin content and basal secretion in pancreatic islets in type 1 diabetic mice. Exp Diabetes Res 481427, 2011.","DOI":"10.1155\/2011\/481427"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Iwabu M, Okada-Iwabu M, Yamauchi T, et al. Adiponectin\/AdipoR research and its implications for lifestyle-related diseases. Front Cardiovasc Med 6: 116, 2019.","DOI":"10.3389\/fcvm.2019.00116"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhou Y, Rui L. Leptin signaling and leptin resistance. Front Med 7: 207-222, 2013.","DOI":"10.1007\/s11684-013-0263-5"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/14\/64_4648-24\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T03:49:57Z","timestamp":1752896997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/64\/14\/64_4648-24\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":14,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4648-24","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"type":"print","value":"0918-2918"},{"type":"electronic","value":"1349-7235"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"article-number":"4648-24"}}